Peter Thiel-backed psychedelics start-up targets schizophrenia ahead of IPO

ATAI Life Science, a Peter Thiel-backed start-up, has taken a majority stake in Recognify, a company that is developing drugs to help treat schizophrenia.

from Health and Science https://ift.tt/2LN6FiF
https://ift.tt/eA8V8J
https://ift.tt/2zIUzyH